ArticleFrontiers in oncology2022

The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy.

Yang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.